ClinicalTrials.gov
ClinicalTrials.gov Menu

LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01485744
Recruitment Status : Active, not recruiting
First Posted : December 5, 2011
Last Update Posted : March 21, 2018
Sponsor:
Collaborator:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Jeffrey W. Clark, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2018
  Estimated Study Completion Date : August 2018